In the early stage of IR, β cells work overload to increase insulin secretion to maintain blood glucose stability, with the compensatory capacity more genetically determined.26 As the disease progresses, β cells are no longer able to secrete enough insulin to compensate for the abnormally high blood glucose, leading to progression to prediabetes or T2D.27 The gene discussed is INS; the disease is type 2 diabetes mellitus.